97 related articles for article (PubMed ID: 1327790)
1. Sparfloxacin in the treatment of males with urethritis.
Tanaka M; Matsumoto T; Kumazawa J; Nagayama A
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):660. PubMed ID: 1327790
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study.
Moi H; Morel P; Gianotti B; Barlow D; Phillips I; Jean C
Drugs; 1995; 49 Suppl 2():387-9. PubMed ID: 8549371
[No Abstract] [Full Text] [Related]
3. A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men.
Phillips I; Dimian C; Barlow D; Moi H; Stolz E; Weidner W; Perea E
J Antimicrob Chemother; 1996 May; 37 Suppl A():123-34. PubMed ID: 8737132
[TBL] [Abstract][Full Text] [Related]
4. Rosoxacin in the treatment of uncomplicated acute gonococcal urethritis.
Vagaskar SR; Fernandez RJ; Wagle UD; Rajani ND
J Postgrad Med; 1990 Oct; 36(4):191-3. PubMed ID: 1966732
[TBL] [Abstract][Full Text] [Related]
5. Development of in-vivo resistance after quinolone treatment of gonococcal urethritis.
Vila J; Olmos L; Ballesteros J; Vázquez JA; Giménez MJ; Marco F; Aguilar L
J Antimicrob Chemother; 1997 Jun; 39(6):841. PubMed ID: 9222062
[No Abstract] [Full Text] [Related]
6. [Grepafloxacin (Raxar)].
Friis HM
Ugeskr Laeger; 1998 Jul; 160(30):4438-41. PubMed ID: 9691842
[No Abstract] [Full Text] [Related]
7. Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men.
Moi H; Morel P; Gianotti B; Barlow D; Phillips I; Jean C
J Antimicrob Chemother; 1996 May; 37 Suppl A():115-22. PubMed ID: 8737131
[TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection.
Kaku M; Ishida K; Kohno S; Koga H; Hara K; Usui T
Drugs; 1995; 49 Suppl 2():412-3. PubMed ID: 8549381
[No Abstract] [Full Text] [Related]
9. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
McDermott-Lancaster RD; Banerjee DK
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):605-8. PubMed ID: 8151193
[TBL] [Abstract][Full Text] [Related]
10. Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected].
Cheong LL; Chan RK; Nadarajah M
Genitourin Med; 1992 Aug; 68(4):260-2. PubMed ID: 1328033
[TBL] [Abstract][Full Text] [Related]
11. Two new fluoroquinolones.
Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
[No Abstract] [Full Text] [Related]
12. Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitis.
Segreti J
Am J Med; 1991 Dec; 91(6A):150S-152S. PubMed ID: 1662887
[TBL] [Abstract][Full Text] [Related]
13. Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.
Niki Y; Tamada S; Nakabayashi M; Soejima R
Drugs; 1995; 49 Suppl 2():420-2. PubMed ID: 8549385
[No Abstract] [Full Text] [Related]
14. Levofloxacin and sparfloxacin: new quinolone antibiotics.
Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
[TBL] [Abstract][Full Text] [Related]
15. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
[No Abstract] [Full Text] [Related]
16. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
Cho N; Miyakawa Z; Kimura T; Shimizu A; Notake Y; Kunii K
Drugs; 1995; 49 Suppl 2():391-2. PubMed ID: 8549373
[No Abstract] [Full Text] [Related]
17. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
Wallrauch C; Voss A; Milatovic D; Braveny I
Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
[TBL] [Abstract][Full Text] [Related]
18. A case of relapsed leprosy successfully treated with sparfloxacin.
Sugita Y; Suga C; Ishii N; Nakajima H
Arch Dermatol; 1996 Nov; 132(11):1397-8. PubMed ID: 8915332
[No Abstract] [Full Text] [Related]
19. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Maserati R; Cagni AE; Segú C
Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
[TBL] [Abstract][Full Text] [Related]
20. Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
Aarestrup FM; Jensen NE; Jorsal SE; Nielsen TK
Vet Rec; 2000 Jan; 146(3):76-8. PubMed ID: 10674696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
